Draft genome sequence of a multidrug-resistant <i>Streptococcus agalactiae</i> sequence type 1665 strain isolated from ascitic fluid
poses a threat due to increasing antimicrobial resistance and the potential for invasive disease. We isolated a sequence type 1665 strain nonsusceptible to β-lactams and resistant to macrolides, tetracyclines, and fluoroquinolones, harboring previously uncharacterized PBP2X variants, highlighting the need for genomic surveillance to guide treatment and infection control.
Authors
- Kazunari Sonobe
- Koh Okamoto (ORCID: https://orcid.org/0000-0002-4072-9096)
- Koji Sasaki (ORCID: https://orcid.org/0000-0002-7027-9188)
- Yusuke Ota (ORCID: https://orcid.org/0000-0002-7754-2508)
- Ryoichi Saito (ORCID: https://orcid.org/0000-0003-3398-8572)
- Saki Kanehira
- Naoya Ichimura
- Yoshiaki Gu
Institutions
- Cardiovascular Institute Hospital (JP)
- University of Tokyo Hospital (JP)
Publication Details
- Journal
- Microbiology Resource Announcements
- Published
- 2026-06-26
- DOI
- https://doi.org/10.1128/mra.00412-26
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science